Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CSX Corporation (CSX) vs GeneDx Holdings Corp (WGS) Price & Performance

CSX CorporationTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

CSX Corporation vs GeneDx Holdings Corp — how do they compare? CSX Corporation trades at $49.91 (market cap $92.55B), while GeneDx Holdings Corp trades at $82.32 (market cap $2.44B). The key difference: CSX Corporation is far larger — about 37.9× GeneDx Holdings Corp's market cap, and CSX Corporation pays a 1.12% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

CSXWGS
Market Cap
$92.55B$2.44B
Sector
IndustrialsTechnology
52-Week High
$53.21$167.51
52-Week Low
$32.05$34.51
Enterprise Value
$110.52B$2.48B
Dividend Yield
1.12%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CSX Corporation

CSX trades at $50.12, down 0.3% on the day, with a neutral technical signal. Recent Q2 2026 earnings beat estimates with EPS of $0.54 versus $0.518 expected, driven by 10% revenue growth and margin expansion. The stock's valuation ratios, including a P/E of 29.05 and P/S of 6.41, reflect a premium pricing relative to historical levels. Analyst consensus is bullish with a $52.57 price target, supported by 58.69% buy ratings.

The outlook for CSX is positive, with projected 2026 revenue growth and improved cash flow. Key opportunities include strong intermodal demand and operational efficiency gains. Risks involve competitive pressures, fuel cost volatility, and potential economic slowdowns affecting freight volumes. The stock's current level offers a moderate upside to the consensus target, balanced by elevated valuation multiples.

GeneDx Holdings Corp

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About CSX Corporation

Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.

Read more on CSX

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS